ilmscore | Prediction Details
"Verve Therapeutics ticker VV is expected to grow Revenue by a stellar 99% this year but then to see it fall by 42% next year for an annualized rate of just 7% over the period"
By Let's Talk Money! with Joseph Hogue, CFA | December 16, 2024 | Pending
From video
23 Penny Stocks Google is Buying Right Now 00:07:10 - 00:07:22
Interpreted Prediction
Verve Therapeutics (VV) revenue predicted to grow 99% in 2024, fall 42% in 2025, resulting in a 7% annualized growth rate over 2024-2025.

Prediction Details

Ticker
VV
Initial Price
279.69 USD

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.